mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...

The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...

Cardio-oncology clinics manage diverse therapy-associated phenotypes including early-onset heart failure, ...

There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...

The personal pain goal is inadequate for assessing outcomes of cancer pain management; goals should include function, medication effects, and safety. Cancer patients need a more comprehensive means of ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

COA survey of independent community oncology practices shows insurer requirements delay treatment, override clinical ...

An expert discusses how multidisciplinary collaboration can be enhanced through shared knowledge of available drugs and biomarkers among oncologists and pathologists, standardized interpretation ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...